About Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
Clinical Trials at Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
During the past decade, Uppsala University Hospital, Dept of Paediatric Haematology and Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology"
#1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
According to Clinical.Site data, the most researched conditions in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology" are
"Leukemia, Acute Lymphoblastic" (2 trials). Many other conditions were trialed in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
Most popular intervention types in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Blinatumomab" (1 trials), "Imatinib" (1 trials), "Inotuzumab Ozogamicin+Standard Maintenance Therapy" (1 trials) and "Observational" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
The vast majority of trials in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Uppsala University Hospital, Dept of Paediatric Haematology and Oncology
Currently, there are NaN active trials in "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Uppsala University Hospital, Dept of Paediatric Haematology and Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Uppsala University Hospital, Dept of Paediatric Haematology and Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".